TY - JOUR
T1 - Effectiveness of the autumn 2023 COVID-19 vaccine dose in hospital-based healthcare workers
T2 - results of the VEBIS healthcare worker vaccine effectiveness cohort study, seven European countries, season 2023/24
AU - VEBIS HCW VE study group
AU - Collaborators in VEBIS HCW study group
AU - Savulescu, Camelia
AU - Prats-Uribe, Albert
AU - Brolin, Kim
AU - Uusküla, Anneli
AU - Bergin, Colm
AU - Fleming, Catherine
AU - Murri, Rita
AU - Zvirbulis, Viesturs
AU - Zavadska, Dace
AU - Gaio, Vania
AU - Popescu, Corneliu P.
AU - Hrisca, Raluca
AU - Cisneros, Maria
AU - Latorre-Millán, Miriam
AU - Lohur, Liis
AU - McGrath, Jonathan
AU - Ferguson, Lauren
AU - De Gaetano Donati, Katleen
AU - Abolina, Ilze
AU - Gravele, Dagne
AU - Machado, Ausenda
AU - Florescu, Simin Aysel
AU - Lazar, Mihaela
AU - Subirats, Pilar
AU - Clusa Cuesta, Laura
AU - Sui, Jacklyn
AU - Kenny, Claire
AU - Santangelo, Rosaria
AU - Krievins, Dainis
AU - Barzdina, Elza Anna
AU - Valadas Henriques, Camila
AU - Kosa, Alma Gabriela
AU - Pohrib, Saftica Mariana
AU - Muñoz-Almagro, Carmen
AU - Milagro, Ana
AU - Bacci, Sabrina
AU - Nardone, Anthony
PY - 2024/10/1
Y1 - 2024/10/1
N2 - COVID-19 vaccination recommendations include healthcare workers (HCWs). We measured COVID-19 vaccine effectiveness (CVE) of the autumn 2023 dose against laboratory-confirmed SARS-CoV-2 infection in a prospective cohort study of 1,305 HCWs from 13 European hospitals. Overall CVE was 22% (95% CI: -17 to 48), 49% (95% CI: -8 to 76) before and -11% (95% CI: -84 to 34) after the start of BA.2.86/JN.1 predominant circulation. Autumn 2023 COVID-19 vaccination led to a moderate-to-low reduction in SARS-CoV-2 infection incidence in HCWs. Monitoring of CVE is crucial for COVID-19 prevention.
AB - COVID-19 vaccination recommendations include healthcare workers (HCWs). We measured COVID-19 vaccine effectiveness (CVE) of the autumn 2023 dose against laboratory-confirmed SARS-CoV-2 infection in a prospective cohort study of 1,305 HCWs from 13 European hospitals. Overall CVE was 22% (95% CI: -17 to 48), 49% (95% CI: -8 to 76) before and -11% (95% CI: -84 to 34) after the start of BA.2.86/JN.1 predominant circulation. Autumn 2023 COVID-19 vaccination led to a moderate-to-low reduction in SARS-CoV-2 infection incidence in HCWs. Monitoring of CVE is crucial for COVID-19 prevention.
KW - COVID-19
KW - Europe
KW - Healthcare workers
KW - SARS-CoV-2
KW - Vaccine effectiveness
UR - http://www.scopus.com/inward/record.url?scp=85208291983&partnerID=8YFLogxK
U2 - 10.2807/1560-7917.ES.2024.29.44.2400680
DO - 10.2807/1560-7917.ES.2024.29.44.2400680
M3 - Article
C2 - 39484687
AN - SCOPUS:85208291983
SN - 1025-496X
VL - 29
JO - Eurosurveillance
JF - Eurosurveillance
IS - 44
ER -
